SlideShare a Scribd company logo
1 of 42
Viral reproductive disorders in sows
           an update 2012


             H. Nauwynck


          Laboratory of Virology
       Faculty of Veterinary Medicine
         Ghent University, Belgium
Normal gestation in the sow

                       2. Cytokine/growth factor
                               cross talk


                                      ?


1. CL (progesterone)
                        3. Immune suppression
How do viruses cause reproductive problems?
 1. General disease (fever) ~ pro-inflammatory cytokines
    causing distortion of cytokine balance
    -> swine influenza virus, …

 2. Replication of pathogens in reproductive
 tract/embryo/fetus      ~ damaging the placenta and/or
 cytokine balance
        ~ direct negative impact on embryo/fetus
     -> DNA viruses: Aujeszky’s disease virus,
 parvovirus,       porcine circovirus 2
     -> RNA viruses: porcine reproductive and respiratory
        syndrome virus, porcine enteroviruses,
        encephalomyocarditis virus, classical swine fever
How do viruses reach embryos/fetuses?

         1. Contaminated sperm
How do viruses reach embryos/fetuses?

                    2. Viremia +
                 transplacental
                          spread
1. Via contaminated
               sperm




Virus excretion in sperm
        ~ viremia
DNA-viruses                 Embryo
ADV (<14 dPI)               Virus rep & †
PPV (<14 dPI)               Virus rep & †   repeat breeding
PCV2 (<50 dPI;>)            Virus rep & †
RNA-viruses
PRRSV (<50 dPI;>)           No virus rep (only infection sow)
PEV (<14 dPI)               Virus rep & † repeat breeding
CSFV (<14 dPI)              Virus rep & †
At what stage can embryos be infected ?


        2-8 cells   morula    blastocyst hatched blastocyst
        (0-4dpins) (4-5dpins) (5-7dpins)      (>7dpins)
ADV         -          -           -              +
PPV         -          -           -              +
PCV2        -          -           -              +

PRRSV       -          -           -              -
PEV         ?          ?           ?              +
CSFV        ?          ?           ?              +
           Virus should resist aggressive uterine
                          environment!!!
        1° difficult to inactivate: PPV, PCV2, PEV (no
Zona pellucida is an ideal barrier




          1° Physical barrier
  Channels in ZP : ± 30 nm (inner ø)
Viruses > 30nm (ADV, PRRSV, CSFV)

         2° Chemical barrier
 Viruses < 30nm (PPV, PCV2, PEV)
Outcome of embryonic PPV-
infection
                Uninfected




 PPV-infected
Outcome of embryonic PCV2-
            infection
                                               Surgical ET




                     HB 6 dpins
                     PCV2/mock



Inspection of
   ovaries
(follicles/CL)
                                               Euthanasia
                                               D14 post ET
            Collection & analysis of embryos
Outcome of embryonic PCV2-
Sow   infection
      Embryos      Embryos       Ovaries
n°  at transfer      at euthanasia
    n°            n° normal degenerated
A         statu   19     19           0     CL
B   s             17     15           2     CL
    26 mock
C   26 mock       13      7          6       CL
D                  3      0          3       CL
E   20             0      0          0    follicles
F         PCV      0      0          0    follicles
G   2              0      0          0    follicles
    23                                                    mock
                                                         normal
          PCV                                            embryo
    2
    20                                        PCV2
          PCV                              degenerated
    2                                        embryo
Outcome of embryonic PCV2-
Sow   infection
      Embryos      Embryos       Ovaries
n°  at transfer      at euthanasia
    n°            n° normal degenerated
A         statu   19     19 0         0     CL
B   s             17     15 0         2 0   CL
    26 mock
C   26 mock       13      74         66    CL
D                  3      0          33    CL
E   20             0      0          0  follicles
F         PCV      0      0          0  follicles
G   2              0      0          0  follicles
                                                    IHC-PCV2
    23
          PCV
    2
    20
          PCV
    2
Outcome of embryonic PCV2-
    Sow   infection
          Embryos      Embryos       Ovaries
    n°    at transfer      at euthanasia
          n°            n° normal degenerated
    A           statu   19     19 0         0      CL
    B     s             17     15 0         2 0    CL
          26 mock
    C     26 mock       13       74         66     CL
    D                    3       0          33     CL
    E     20             0       0          0   follicles
    F           PCV      0       0          0   follicles
    G     2              0       0          0   follicles
                                                            IHC-PCV2
          23
PCV2 infection of embryos leads to
                PCV
• embryonic death
          2
          20
• return to oestrus of sow (regular/irregular)
                PCV
• both PCV2a and PCV2b
          2
2. Viremia + transplacental spread




                                             DNA-viruses
                                         (PPV, PCV2, ADV)

                                              RNA-viruses
                                           (PRRSV, CSFV,
                                    PEV 1, 3, 6 & 8, EMCV)

                        • Cell-free: PPV, PEV, PRRSV, EMCV
                        • Cell-associated: ADV, PCV2, CSFV
Transplacental
spread -
cell free virus

        PRRSV (> 70dpi)
                              *   *
        PPV, PEV, EMCV    *
                          *   *   *
Normal
placenta

fetal site




maternal site
Transplacental spread - PRRSV - 1. cell free virus + free mø
Transplacental spread - PRRSV - 2. cell free virus +
migrating mø
Transplacental spread - PRRSV - 3. infection of migrating
mø
Transplacental spread - PRRSV - 4. entry of fetal placenta
                               by migrating mø
Transplacental spread - PRRSV - 5. explosive replication in
                               fetal placental mø
Transplacental spread - PRRSV - 6. apoptosis in infected
mø
                               and bystander cells
Transplacental spread - PRRSV - 7. apoptosis in infected
mø
                               and bystander
cells/necrosis?
Transplacental spread - PRRSV - 8. dysfunction placenta
Transplacental spread - PRRSV - 8. dysfunction placenta
Transplacental
spread -
cell-associated virus


      PCV2, ADV, CSFV   *      *     * *
                        *          * *
                            * * * * *
                            ** * * * *
                               *       * **
Cell-associated transplacental spread of ADV


                    Maternal
                    placenta




        Maternal                          Fetal
        placenta                       placenta
Interfetal virus spread




*
Clinical outcome - fetus

        Infection time (days of gestation)
        0-30 30-60 60-90 90-113
ADV      †       †        †        †
PPV      †       †       †/IR     IR
PCV2     †       †       †/IR     IR

PRRSV    -       (†)       †       †/IR
PEV      †        †       †/IR      IR
CSFV     †      †/IT      †/IR     †/IR
               terato


                        IR immune response
                        IT immune tolerance
Clinical outcome - sow


               Infection time (days of gestation)
        0-30       30-60          60-90             90-113
ADV     repeat br. abortion       abortion          abortion/msw
PPV     repeat br. msw            msw               normal
PCV2    repeat br. msw            msw               normal

PRRSV -          -           late abortion/msw late abortion/msw
PEV   repeat br. msw         msw               normal
CSFV repeat br. abortion/msw abortion/msw      abortion/msw



msw: mummies, stillborn and weakborn piglets at birth
ADV
PPV




Inoculated po at 47 days of gestation   Natural case
 Euthanized at 81 days of gestation       At birth
Inoculated at 43 days of gestation
PPV   Euthanized at 98 days of gestation
PCV2
   Inoculated       Aspect     Virus         Abs   Intra-uterine    Interruption
(days of gestation) at birth                          spread        of gestation

       57        mummified      +             -        +                    -

      75           stillborn
                                +             +         -                   -
                   autolytic

      92           normal       +             +         -                   -




        mummified                      autolytic                   normal
PCV2
              inoculated at 57 days of gestation
              collected at 21 days PI


                                      Ascites,
                                   congestion
                            of internal organs




Myocarditis                                        At birth




                                                   mummified
PRRSV
PEV




      Inoculated in fetus 8
      at 59 days of gestation

      Hysterectomy at 113 days
      of gestation

      7 living fetuses
CSFV




Inoculation of CSFV (low virulence) po at 43 days of gestation
                   Collection at parturition
Reproductive failure - Diagnosis?
Main complaint: abortion ≠ stages of gestation



              Fetuses                          Fetuses
     fresh, rigor mortis (firm)    not fresh, partially mummified


            Sera sow                   Lungs/spleen fetuses
                                   (esp. with necrotic foci in liver)
                                         No serum sows!!!
         Seroconversion

     SIV or other pathogen              Immunofluorescence
    causing general disease              Virus isolation/PCR
             fever                           ADV, CSFV
Reproductive failure - Diagnosis?
Main complaint: SMEDI
                   Fetuses/piglets at birth
        Mummies (≠ stages), stillborn and normal piglets


        1) Heart/spleen/lungs fetuses (<70 dpins; <17cm)
         2) Body fluid/serum fetuses (>70dpins; >17cm)
                        No serum sows!!!


                     1) Virus isolation/PCR
      2) Antibody detection (BE CAREFULL WITH PCV2!!!)

                    PPV, PCV2, PEV, EMCV
Reproductive failure - Diagnosis?
Main complaint: late abortion/early farrowing
              Fetuses at late abortion/early farrowing
Early stages of mummification (brown), stillborn and normal piglets


                 Placenta/lungs/spleen fetuses
          Serum stillborn/piglets before colostrum uptake
                         No serum sows!!!


                      Virus isolation(±)/PCR


                              PRRSV
Virus-embryo/fetus work

         Laboratory of Virology
& Laboratory of Reproductive Technology
     Faculty of Veterinary Medicine
       Ghent University, Belgium


             H. Nauwynck
             A. Van Soom
              G. Labarque
              R. Sanchez
              G. Vanroose
               S. Tanghe
              B. Mateusen
                P. Meerts
              D. Lefebvre
                 D. Saha
             U. Karniychuk
                  I. Trus
                 J. Beek

More Related Content

What's hot

Structure of Hepatitis
Structure of HepatitisStructure of Hepatitis
Structure of HepatitisPavithra B R
 
Aasv2014 daresta et al. comparative pcv2 fetal protection-poster
Aasv2014 daresta et al. comparative pcv2 fetal protection-posterAasv2014 daresta et al. comparative pcv2 fetal protection-poster
Aasv2014 daresta et al. comparative pcv2 fetal protection-posterMerial EMEA
 
T Monath et al West Nile PNAS
T Monath et al West Nile PNAST Monath et al West Nile PNAS
T Monath et al West Nile PNASThomas Ermak
 
Skowronski samhd1-20121105
Skowronski samhd1-20121105Skowronski samhd1-20121105
Skowronski samhd1-20121105Kimberly Schafer
 
DEL's Vi bacteriophage talk final
DEL's Vi bacteriophage talk finalDEL's Vi bacteriophage talk final
DEL's Vi bacteriophage talk finalDerek Pickard
 

What's hot (6)

Structure of Hepatitis
Structure of HepatitisStructure of Hepatitis
Structure of Hepatitis
 
Aasv2014 daresta et al. comparative pcv2 fetal protection-poster
Aasv2014 daresta et al. comparative pcv2 fetal protection-posterAasv2014 daresta et al. comparative pcv2 fetal protection-poster
Aasv2014 daresta et al. comparative pcv2 fetal protection-poster
 
T Monath et al West Nile PNAS
T Monath et al West Nile PNAST Monath et al West Nile PNAS
T Monath et al West Nile PNAS
 
Skowronski samhd1-20121105
Skowronski samhd1-20121105Skowronski samhd1-20121105
Skowronski samhd1-20121105
 
DEL's Vi bacteriophage talk final
DEL's Vi bacteriophage talk finalDEL's Vi bacteriophage talk final
DEL's Vi bacteriophage talk final
 
presentation-Honors 2013
presentation-Honors 2013presentation-Honors 2013
presentation-Honors 2013
 

Similar to 12 merialberlinhansnauwynck

02 perreul relu 13 avril soir
02 perreul relu 13 avril soir02 perreul relu 13 avril soir
02 perreul relu 13 avril soirMerial EMEA
 
02 perreul relu 13 avril soir
02 perreul relu 13 avril soir02 perreul relu 13 avril soir
02 perreul relu 13 avril soirMerial EMEA
 
Dr. Michael Murtaugh and Dr. Cheryl Dvorak - Natural Infection, Immunity & Pr...
Dr. Michael Murtaugh and Dr. Cheryl Dvorak - Natural Infection, Immunity & Pr...Dr. Michael Murtaugh and Dr. Cheryl Dvorak - Natural Infection, Immunity & Pr...
Dr. Michael Murtaugh and Dr. Cheryl Dvorak - Natural Infection, Immunity & Pr...John Blue
 
Emerging Viral Risks and Mitigation Strategies in Biologics Manufacturing
Emerging Viral Risks and Mitigation Strategies in Biologics ManufacturingEmerging Viral Risks and Mitigation Strategies in Biologics Manufacturing
Emerging Viral Risks and Mitigation Strategies in Biologics ManufacturingMilliporeSigma
 
Emerging Viral Risks and Mitigation Strategies in Biologics Manufacturing
Emerging Viral Risks and Mitigation Strategies in Biologics ManufacturingEmerging Viral Risks and Mitigation Strategies in Biologics Manufacturing
Emerging Viral Risks and Mitigation Strategies in Biologics ManufacturingMerck Life Sciences
 
Dr. Michael Murtaugh and Dr. Cheryl Dvorak - Natural Infection, Immunity & Pr...
Dr. Michael Murtaugh and Dr. Cheryl Dvorak - Natural Infection, Immunity & Pr...Dr. Michael Murtaugh and Dr. Cheryl Dvorak - Natural Infection, Immunity & Pr...
Dr. Michael Murtaugh and Dr. Cheryl Dvorak - Natural Infection, Immunity & Pr...John Blue
 
Modified chickenpox formated
Modified chickenpox formatedModified chickenpox formated
Modified chickenpox formatedAmir Mahmoud
 
01 sergio lopez soria
01 sergio lopez soria01 sergio lopez soria
01 sergio lopez soriaMerial EMEA
 
Poster benito SIDiLV BVD/BDV
Poster benito SIDiLV BVD/BDVPoster benito SIDiLV BVD/BDV
Poster benito SIDiLV BVD/BDVSergio Exopol
 

Similar to 12 merialberlinhansnauwynck (20)

07 qjegales
07 qjegales07 qjegales
07 qjegales
 
02 perreul relu 13 avril soir
02 perreul relu 13 avril soir02 perreul relu 13 avril soir
02 perreul relu 13 avril soir
 
02 perreul relu 13 avril soir
02 perreul relu 13 avril soir02 perreul relu 13 avril soir
02 perreul relu 13 avril soir
 
02 perreul
02 perreul 02 perreul
02 perreul
 
Dr. Michael Murtaugh and Dr. Cheryl Dvorak - Natural Infection, Immunity & Pr...
Dr. Michael Murtaugh and Dr. Cheryl Dvorak - Natural Infection, Immunity & Pr...Dr. Michael Murtaugh and Dr. Cheryl Dvorak - Natural Infection, Immunity & Pr...
Dr. Michael Murtaugh and Dr. Cheryl Dvorak - Natural Infection, Immunity & Pr...
 
02 pcvd g sarli
02 pcvd g sarli02 pcvd g sarli
02 pcvd g sarli
 
Emerging Viral Risks and Mitigation Strategies in Biologics Manufacturing
Emerging Viral Risks and Mitigation Strategies in Biologics ManufacturingEmerging Viral Risks and Mitigation Strategies in Biologics Manufacturing
Emerging Viral Risks and Mitigation Strategies in Biologics Manufacturing
 
Emerging Viral Risks and Mitigation Strategies in Biologics Manufacturing
Emerging Viral Risks and Mitigation Strategies in Biologics ManufacturingEmerging Viral Risks and Mitigation Strategies in Biologics Manufacturing
Emerging Viral Risks and Mitigation Strategies in Biologics Manufacturing
 
Infectious uveitis dr martinez (1)
Infectious uveitis dr martinez (1)Infectious uveitis dr martinez (1)
Infectious uveitis dr martinez (1)
 
BK Virus Nephropathy
BK Virus NephropathyBK Virus Nephropathy
BK Virus Nephropathy
 
Dr. Michael Murtaugh and Dr. Cheryl Dvorak - Natural Infection, Immunity & Pr...
Dr. Michael Murtaugh and Dr. Cheryl Dvorak - Natural Infection, Immunity & Pr...Dr. Michael Murtaugh and Dr. Cheryl Dvorak - Natural Infection, Immunity & Pr...
Dr. Michael Murtaugh and Dr. Cheryl Dvorak - Natural Infection, Immunity & Pr...
 
polyoma virus
polyoma viruspolyoma virus
polyoma virus
 
Modified chickenpox formated
Modified chickenpox formatedModified chickenpox formated
Modified chickenpox formated
 
01 sergio lopez soria
01 sergio lopez soria01 sergio lopez soria
01 sergio lopez soria
 
Bi curs an5 panleucopenia felina
Bi curs an5 panleucopenia felinaBi curs an5 panleucopenia felina
Bi curs an5 panleucopenia felina
 
Rift valley fever ppt.
Rift valley fever ppt.Rift valley fever ppt.
Rift valley fever ppt.
 
Newcastle disease
Newcastle diseaseNewcastle disease
Newcastle disease
 
Poster benito SIDiLV BVD/BDV
Poster benito SIDiLV BVD/BDVPoster benito SIDiLV BVD/BDV
Poster benito SIDiLV BVD/BDV
 
New Castle Disease
New Castle DiseaseNew Castle Disease
New Castle Disease
 
(20071002)
(20071002)(20071002)
(20071002)
 

More from Merial EMEA

VAXXITEK HVT + IBD - Field Study - Spain - Merial
VAXXITEK HVT + IBD - Field Study - Spain - MerialVAXXITEK HVT + IBD - Field Study - Spain - Merial
VAXXITEK HVT + IBD - Field Study - Spain - MerialMerial EMEA
 
VAXXITEK HVT + IBD - Field Study - Brazil - Merial
VAXXITEK HVT + IBD - Field Study - Brazil - MerialVAXXITEK HVT + IBD - Field Study - Brazil - Merial
VAXXITEK HVT + IBD - Field Study - Brazil - MerialMerial EMEA
 
VAXXITEK HVT + IBD - Field Study - Egypt - Merial
VAXXITEK HVT + IBD - Field Study - Egypt - MerialVAXXITEK HVT + IBD - Field Study - Egypt - Merial
VAXXITEK HVT + IBD - Field Study - Egypt - MerialMerial EMEA
 
VAXXITEK HVT + IBD - Field Study - China - Merial
VAXXITEK HVT + IBD - Field Study - China - MerialVAXXITEK HVT + IBD - Field Study - China - Merial
VAXXITEK HVT + IBD - Field Study - China - MerialMerial EMEA
 
VAXXITEK HVT + IBD - Field Study - United Kingdom - Merial
VAXXITEK HVT + IBD - Field Study - United Kingdom - MerialVAXXITEK HVT + IBD - Field Study - United Kingdom - Merial
VAXXITEK HVT + IBD - Field Study - United Kingdom - MerialMerial EMEA
 
VAXXITEK HVT + IBD - Field Study - France - Merial
VAXXITEK HVT + IBD - Field Study - France - MerialVAXXITEK HVT + IBD - Field Study - France - Merial
VAXXITEK HVT + IBD - Field Study - France - MerialMerial EMEA
 
Apvs2013 09 vosloo et al.-o1 manisa efficacy vs viet fmd strain in pig
Apvs2013 09 vosloo et al.-o1 manisa efficacy vs viet fmd strain in pigApvs2013 09 vosloo et al.-o1 manisa efficacy vs viet fmd strain in pig
Apvs2013 09 vosloo et al.-o1 manisa efficacy vs viet fmd strain in pigMerial EMEA
 
Apvs2013 04 kagawa et al.-importance of continuation of pcv2 sow vaccination ...
Apvs2013 04 kagawa et al.-importance of continuation of pcv2 sow vaccination ...Apvs2013 04 kagawa et al.-importance of continuation of pcv2 sow vaccination ...
Apvs2013 04 kagawa et al.-importance of continuation of pcv2 sow vaccination ...Merial EMEA
 
Chapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sows
Chapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sowsChapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sows
Chapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sowsMerial EMEA
 
Apvs2013 02 merdy et al.-comparison circovac vs competitors on adwg mortality...
Apvs2013 02 merdy et al.-comparison circovac vs competitors on adwg mortality...Apvs2013 02 merdy et al.-comparison circovac vs competitors on adwg mortality...
Apvs2013 02 merdy et al.-comparison circovac vs competitors on adwg mortality...Merial EMEA
 
Apvs2013 01 merdy et al.-circovac pmr calculation
Apvs2013 01 merdy et al.-circovac pmr calculationApvs2013 01 merdy et al.-circovac pmr calculation
Apvs2013 01 merdy et al.-circovac pmr calculationMerial EMEA
 
Apvs2013 10 lee et al.-trypanosomiasis in pigs in malaysia
Apvs2013 10 lee et al.-trypanosomiasis in pigs in malaysiaApvs2013 10 lee et al.-trypanosomiasis in pigs in malaysia
Apvs2013 10 lee et al.-trypanosomiasis in pigs in malaysiaMerial EMEA
 
Apvs2013 08 tee et al.-csf test kit comparison
Apvs2013 08 tee et al.-csf test kit comparisonApvs2013 08 tee et al.-csf test kit comparison
Apvs2013 08 tee et al.-csf test kit comparisonMerial EMEA
 
Apvs2013 07 tonelli and galuppini- serological survey of akipor mixed with gr...
Apvs2013 07 tonelli and galuppini- serological survey of akipor mixed with gr...Apvs2013 07 tonelli and galuppini- serological survey of akipor mixed with gr...
Apvs2013 07 tonelli and galuppini- serological survey of akipor mixed with gr...Merial EMEA
 
Salvini et al.-Introduction of prssv vaccination with PROGRESSIS® in an itali...
Salvini et al.-Introduction of prssv vaccination with PROGRESSIS® in an itali...Salvini et al.-Introduction of prssv vaccination with PROGRESSIS® in an itali...
Salvini et al.-Introduction of prssv vaccination with PROGRESSIS® in an itali...Merial EMEA
 
Apvs2013 06 castellan et al.-clinical case report of h1 n1pdm in italy
Apvs2013 06 castellan et al.-clinical case report of h1 n1pdm in italyApvs2013 06 castellan et al.-clinical case report of h1 n1pdm in italy
Apvs2013 06 castellan et al.-clinical case report of h1 n1pdm in italyMerial EMEA
 
Vila et al. Improvement of herd performance parameters after sow and piglet v...
Vila et al. Improvement of herd performance parameters after sow and piglet v...Vila et al. Improvement of herd performance parameters after sow and piglet v...
Vila et al. Improvement of herd performance parameters after sow and piglet v...Merial EMEA
 
Aasv2014 callen et al. vaccination compliance to pcv2 using a dth test
Aasv2014 callen et al. vaccination compliance to pcv2 using a dth testAasv2014 callen et al. vaccination compliance to pcv2 using a dth test
Aasv2014 callen et al. vaccination compliance to pcv2 using a dth testMerial EMEA
 
ESPHM2014 MERIAL Momentum
ESPHM2014 MERIAL MomentumESPHM2014 MERIAL Momentum
ESPHM2014 MERIAL MomentumMerial EMEA
 
ESPHM 2014 MERIAL momentum cover
ESPHM 2014 MERIAL momentum coverESPHM 2014 MERIAL momentum cover
ESPHM 2014 MERIAL momentum coverMerial EMEA
 

More from Merial EMEA (20)

VAXXITEK HVT + IBD - Field Study - Spain - Merial
VAXXITEK HVT + IBD - Field Study - Spain - MerialVAXXITEK HVT + IBD - Field Study - Spain - Merial
VAXXITEK HVT + IBD - Field Study - Spain - Merial
 
VAXXITEK HVT + IBD - Field Study - Brazil - Merial
VAXXITEK HVT + IBD - Field Study - Brazil - MerialVAXXITEK HVT + IBD - Field Study - Brazil - Merial
VAXXITEK HVT + IBD - Field Study - Brazil - Merial
 
VAXXITEK HVT + IBD - Field Study - Egypt - Merial
VAXXITEK HVT + IBD - Field Study - Egypt - MerialVAXXITEK HVT + IBD - Field Study - Egypt - Merial
VAXXITEK HVT + IBD - Field Study - Egypt - Merial
 
VAXXITEK HVT + IBD - Field Study - China - Merial
VAXXITEK HVT + IBD - Field Study - China - MerialVAXXITEK HVT + IBD - Field Study - China - Merial
VAXXITEK HVT + IBD - Field Study - China - Merial
 
VAXXITEK HVT + IBD - Field Study - United Kingdom - Merial
VAXXITEK HVT + IBD - Field Study - United Kingdom - MerialVAXXITEK HVT + IBD - Field Study - United Kingdom - Merial
VAXXITEK HVT + IBD - Field Study - United Kingdom - Merial
 
VAXXITEK HVT + IBD - Field Study - France - Merial
VAXXITEK HVT + IBD - Field Study - France - MerialVAXXITEK HVT + IBD - Field Study - France - Merial
VAXXITEK HVT + IBD - Field Study - France - Merial
 
Apvs2013 09 vosloo et al.-o1 manisa efficacy vs viet fmd strain in pig
Apvs2013 09 vosloo et al.-o1 manisa efficacy vs viet fmd strain in pigApvs2013 09 vosloo et al.-o1 manisa efficacy vs viet fmd strain in pig
Apvs2013 09 vosloo et al.-o1 manisa efficacy vs viet fmd strain in pig
 
Apvs2013 04 kagawa et al.-importance of continuation of pcv2 sow vaccination ...
Apvs2013 04 kagawa et al.-importance of continuation of pcv2 sow vaccination ...Apvs2013 04 kagawa et al.-importance of continuation of pcv2 sow vaccination ...
Apvs2013 04 kagawa et al.-importance of continuation of pcv2 sow vaccination ...
 
Chapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sows
Chapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sowsChapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sows
Chapat et al.-orf1 et orf2 cmi with CIRCOVAC vaccination in sows
 
Apvs2013 02 merdy et al.-comparison circovac vs competitors on adwg mortality...
Apvs2013 02 merdy et al.-comparison circovac vs competitors on adwg mortality...Apvs2013 02 merdy et al.-comparison circovac vs competitors on adwg mortality...
Apvs2013 02 merdy et al.-comparison circovac vs competitors on adwg mortality...
 
Apvs2013 01 merdy et al.-circovac pmr calculation
Apvs2013 01 merdy et al.-circovac pmr calculationApvs2013 01 merdy et al.-circovac pmr calculation
Apvs2013 01 merdy et al.-circovac pmr calculation
 
Apvs2013 10 lee et al.-trypanosomiasis in pigs in malaysia
Apvs2013 10 lee et al.-trypanosomiasis in pigs in malaysiaApvs2013 10 lee et al.-trypanosomiasis in pigs in malaysia
Apvs2013 10 lee et al.-trypanosomiasis in pigs in malaysia
 
Apvs2013 08 tee et al.-csf test kit comparison
Apvs2013 08 tee et al.-csf test kit comparisonApvs2013 08 tee et al.-csf test kit comparison
Apvs2013 08 tee et al.-csf test kit comparison
 
Apvs2013 07 tonelli and galuppini- serological survey of akipor mixed with gr...
Apvs2013 07 tonelli and galuppini- serological survey of akipor mixed with gr...Apvs2013 07 tonelli and galuppini- serological survey of akipor mixed with gr...
Apvs2013 07 tonelli and galuppini- serological survey of akipor mixed with gr...
 
Salvini et al.-Introduction of prssv vaccination with PROGRESSIS® in an itali...
Salvini et al.-Introduction of prssv vaccination with PROGRESSIS® in an itali...Salvini et al.-Introduction of prssv vaccination with PROGRESSIS® in an itali...
Salvini et al.-Introduction of prssv vaccination with PROGRESSIS® in an itali...
 
Apvs2013 06 castellan et al.-clinical case report of h1 n1pdm in italy
Apvs2013 06 castellan et al.-clinical case report of h1 n1pdm in italyApvs2013 06 castellan et al.-clinical case report of h1 n1pdm in italy
Apvs2013 06 castellan et al.-clinical case report of h1 n1pdm in italy
 
Vila et al. Improvement of herd performance parameters after sow and piglet v...
Vila et al. Improvement of herd performance parameters after sow and piglet v...Vila et al. Improvement of herd performance parameters after sow and piglet v...
Vila et al. Improvement of herd performance parameters after sow and piglet v...
 
Aasv2014 callen et al. vaccination compliance to pcv2 using a dth test
Aasv2014 callen et al. vaccination compliance to pcv2 using a dth testAasv2014 callen et al. vaccination compliance to pcv2 using a dth test
Aasv2014 callen et al. vaccination compliance to pcv2 using a dth test
 
ESPHM2014 MERIAL Momentum
ESPHM2014 MERIAL MomentumESPHM2014 MERIAL Momentum
ESPHM2014 MERIAL Momentum
 
ESPHM 2014 MERIAL momentum cover
ESPHM 2014 MERIAL momentum coverESPHM 2014 MERIAL momentum cover
ESPHM 2014 MERIAL momentum cover
 

Recently uploaded

Salesforce Community Group Quito, Salesforce 101
Salesforce Community Group Quito, Salesforce 101Salesforce Community Group Quito, Salesforce 101
Salesforce Community Group Quito, Salesforce 101Paola De la Torre
 
WhatsApp 9892124323 ✓Call Girls In Kalyan ( Mumbai ) secure service
WhatsApp 9892124323 ✓Call Girls In Kalyan ( Mumbai ) secure serviceWhatsApp 9892124323 ✓Call Girls In Kalyan ( Mumbai ) secure service
WhatsApp 9892124323 ✓Call Girls In Kalyan ( Mumbai ) secure servicePooja Nehwal
 
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
04-2024-HHUG-Sales-and-Marketing-Alignment.pptxHampshireHUG
 
Understanding the Laravel MVC Architecture
Understanding the Laravel MVC ArchitectureUnderstanding the Laravel MVC Architecture
Understanding the Laravel MVC ArchitecturePixlogix Infotech
 
A Domino Admins Adventures (Engage 2024)
A Domino Admins Adventures (Engage 2024)A Domino Admins Adventures (Engage 2024)
A Domino Admins Adventures (Engage 2024)Gabriella Davis
 
Breaking the Kubernetes Kill Chain: Host Path Mount
Breaking the Kubernetes Kill Chain: Host Path MountBreaking the Kubernetes Kill Chain: Host Path Mount
Breaking the Kubernetes Kill Chain: Host Path MountPuma Security, LLC
 
Key Features Of Token Development (1).pptx
Key  Features Of Token  Development (1).pptxKey  Features Of Token  Development (1).pptx
Key Features Of Token Development (1).pptxLBM Solutions
 
Enhancing Worker Digital Experience: A Hands-on Workshop for Partners
Enhancing Worker Digital Experience: A Hands-on Workshop for PartnersEnhancing Worker Digital Experience: A Hands-on Workshop for Partners
Enhancing Worker Digital Experience: A Hands-on Workshop for PartnersThousandEyes
 
IAC 2024 - IA Fast Track to Search Focused AI Solutions
IAC 2024 - IA Fast Track to Search Focused AI SolutionsIAC 2024 - IA Fast Track to Search Focused AI Solutions
IAC 2024 - IA Fast Track to Search Focused AI SolutionsEnterprise Knowledge
 
SQL Database Design For Developers at php[tek] 2024
SQL Database Design For Developers at php[tek] 2024SQL Database Design For Developers at php[tek] 2024
SQL Database Design For Developers at php[tek] 2024Scott Keck-Warren
 
FULL ENJOY 🔝 8264348440 🔝 Call Girls in Diplomatic Enclave | Delhi
FULL ENJOY 🔝 8264348440 🔝 Call Girls in Diplomatic Enclave | DelhiFULL ENJOY 🔝 8264348440 🔝 Call Girls in Diplomatic Enclave | Delhi
FULL ENJOY 🔝 8264348440 🔝 Call Girls in Diplomatic Enclave | Delhisoniya singh
 
Automating Business Process via MuleSoft Composer | Bangalore MuleSoft Meetup...
Automating Business Process via MuleSoft Composer | Bangalore MuleSoft Meetup...Automating Business Process via MuleSoft Composer | Bangalore MuleSoft Meetup...
Automating Business Process via MuleSoft Composer | Bangalore MuleSoft Meetup...shyamraj55
 
[2024]Digital Global Overview Report 2024 Meltwater.pdf
[2024]Digital Global Overview Report 2024 Meltwater.pdf[2024]Digital Global Overview Report 2024 Meltwater.pdf
[2024]Digital Global Overview Report 2024 Meltwater.pdfhans926745
 
How to convert PDF to text with Nanonets
How to convert PDF to text with NanonetsHow to convert PDF to text with Nanonets
How to convert PDF to text with Nanonetsnaman860154
 
08448380779 Call Girls In Civil Lines Women Seeking Men
08448380779 Call Girls In Civil Lines Women Seeking Men08448380779 Call Girls In Civil Lines Women Seeking Men
08448380779 Call Girls In Civil Lines Women Seeking MenDelhi Call girls
 
Slack Application Development 101 Slides
Slack Application Development 101 SlidesSlack Application Development 101 Slides
Slack Application Development 101 Slidespraypatel2
 
Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365
Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365
Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 3652toLead Limited
 
Beyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
Beyond Boundaries: Leveraging No-Code Solutions for Industry InnovationBeyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
Beyond Boundaries: Leveraging No-Code Solutions for Industry InnovationSafe Software
 
08448380779 Call Girls In Diplomatic Enclave Women Seeking Men
08448380779 Call Girls In Diplomatic Enclave Women Seeking Men08448380779 Call Girls In Diplomatic Enclave Women Seeking Men
08448380779 Call Girls In Diplomatic Enclave Women Seeking MenDelhi Call girls
 
08448380779 Call Girls In Friends Colony Women Seeking Men
08448380779 Call Girls In Friends Colony Women Seeking Men08448380779 Call Girls In Friends Colony Women Seeking Men
08448380779 Call Girls In Friends Colony Women Seeking MenDelhi Call girls
 

Recently uploaded (20)

Salesforce Community Group Quito, Salesforce 101
Salesforce Community Group Quito, Salesforce 101Salesforce Community Group Quito, Salesforce 101
Salesforce Community Group Quito, Salesforce 101
 
WhatsApp 9892124323 ✓Call Girls In Kalyan ( Mumbai ) secure service
WhatsApp 9892124323 ✓Call Girls In Kalyan ( Mumbai ) secure serviceWhatsApp 9892124323 ✓Call Girls In Kalyan ( Mumbai ) secure service
WhatsApp 9892124323 ✓Call Girls In Kalyan ( Mumbai ) secure service
 
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
 
Understanding the Laravel MVC Architecture
Understanding the Laravel MVC ArchitectureUnderstanding the Laravel MVC Architecture
Understanding the Laravel MVC Architecture
 
A Domino Admins Adventures (Engage 2024)
A Domino Admins Adventures (Engage 2024)A Domino Admins Adventures (Engage 2024)
A Domino Admins Adventures (Engage 2024)
 
Breaking the Kubernetes Kill Chain: Host Path Mount
Breaking the Kubernetes Kill Chain: Host Path MountBreaking the Kubernetes Kill Chain: Host Path Mount
Breaking the Kubernetes Kill Chain: Host Path Mount
 
Key Features Of Token Development (1).pptx
Key  Features Of Token  Development (1).pptxKey  Features Of Token  Development (1).pptx
Key Features Of Token Development (1).pptx
 
Enhancing Worker Digital Experience: A Hands-on Workshop for Partners
Enhancing Worker Digital Experience: A Hands-on Workshop for PartnersEnhancing Worker Digital Experience: A Hands-on Workshop for Partners
Enhancing Worker Digital Experience: A Hands-on Workshop for Partners
 
IAC 2024 - IA Fast Track to Search Focused AI Solutions
IAC 2024 - IA Fast Track to Search Focused AI SolutionsIAC 2024 - IA Fast Track to Search Focused AI Solutions
IAC 2024 - IA Fast Track to Search Focused AI Solutions
 
SQL Database Design For Developers at php[tek] 2024
SQL Database Design For Developers at php[tek] 2024SQL Database Design For Developers at php[tek] 2024
SQL Database Design For Developers at php[tek] 2024
 
FULL ENJOY 🔝 8264348440 🔝 Call Girls in Diplomatic Enclave | Delhi
FULL ENJOY 🔝 8264348440 🔝 Call Girls in Diplomatic Enclave | DelhiFULL ENJOY 🔝 8264348440 🔝 Call Girls in Diplomatic Enclave | Delhi
FULL ENJOY 🔝 8264348440 🔝 Call Girls in Diplomatic Enclave | Delhi
 
Automating Business Process via MuleSoft Composer | Bangalore MuleSoft Meetup...
Automating Business Process via MuleSoft Composer | Bangalore MuleSoft Meetup...Automating Business Process via MuleSoft Composer | Bangalore MuleSoft Meetup...
Automating Business Process via MuleSoft Composer | Bangalore MuleSoft Meetup...
 
[2024]Digital Global Overview Report 2024 Meltwater.pdf
[2024]Digital Global Overview Report 2024 Meltwater.pdf[2024]Digital Global Overview Report 2024 Meltwater.pdf
[2024]Digital Global Overview Report 2024 Meltwater.pdf
 
How to convert PDF to text with Nanonets
How to convert PDF to text with NanonetsHow to convert PDF to text with Nanonets
How to convert PDF to text with Nanonets
 
08448380779 Call Girls In Civil Lines Women Seeking Men
08448380779 Call Girls In Civil Lines Women Seeking Men08448380779 Call Girls In Civil Lines Women Seeking Men
08448380779 Call Girls In Civil Lines Women Seeking Men
 
Slack Application Development 101 Slides
Slack Application Development 101 SlidesSlack Application Development 101 Slides
Slack Application Development 101 Slides
 
Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365
Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365
Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365
 
Beyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
Beyond Boundaries: Leveraging No-Code Solutions for Industry InnovationBeyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
Beyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
 
08448380779 Call Girls In Diplomatic Enclave Women Seeking Men
08448380779 Call Girls In Diplomatic Enclave Women Seeking Men08448380779 Call Girls In Diplomatic Enclave Women Seeking Men
08448380779 Call Girls In Diplomatic Enclave Women Seeking Men
 
08448380779 Call Girls In Friends Colony Women Seeking Men
08448380779 Call Girls In Friends Colony Women Seeking Men08448380779 Call Girls In Friends Colony Women Seeking Men
08448380779 Call Girls In Friends Colony Women Seeking Men
 

12 merialberlinhansnauwynck

  • 1. Viral reproductive disorders in sows an update 2012 H. Nauwynck Laboratory of Virology Faculty of Veterinary Medicine Ghent University, Belgium
  • 2. Normal gestation in the sow 2. Cytokine/growth factor cross talk ? 1. CL (progesterone) 3. Immune suppression
  • 3. How do viruses cause reproductive problems? 1. General disease (fever) ~ pro-inflammatory cytokines causing distortion of cytokine balance -> swine influenza virus, … 2. Replication of pathogens in reproductive tract/embryo/fetus ~ damaging the placenta and/or cytokine balance ~ direct negative impact on embryo/fetus -> DNA viruses: Aujeszky’s disease virus, parvovirus, porcine circovirus 2 -> RNA viruses: porcine reproductive and respiratory syndrome virus, porcine enteroviruses, encephalomyocarditis virus, classical swine fever
  • 4. How do viruses reach embryos/fetuses? 1. Contaminated sperm
  • 5. How do viruses reach embryos/fetuses? 2. Viremia + transplacental spread
  • 6. 1. Via contaminated sperm Virus excretion in sperm ~ viremia DNA-viruses Embryo ADV (<14 dPI) Virus rep & † PPV (<14 dPI) Virus rep & † repeat breeding PCV2 (<50 dPI;>) Virus rep & † RNA-viruses PRRSV (<50 dPI;>) No virus rep (only infection sow) PEV (<14 dPI) Virus rep & † repeat breeding CSFV (<14 dPI) Virus rep & †
  • 7. At what stage can embryos be infected ? 2-8 cells morula blastocyst hatched blastocyst (0-4dpins) (4-5dpins) (5-7dpins) (>7dpins) ADV - - - + PPV - - - + PCV2 - - - + PRRSV - - - - PEV ? ? ? + CSFV ? ? ? + Virus should resist aggressive uterine environment!!! 1° difficult to inactivate: PPV, PCV2, PEV (no
  • 8. Zona pellucida is an ideal barrier 1° Physical barrier Channels in ZP : ± 30 nm (inner ø) Viruses > 30nm (ADV, PRRSV, CSFV) 2° Chemical barrier Viruses < 30nm (PPV, PCV2, PEV)
  • 9. Outcome of embryonic PPV- infection Uninfected PPV-infected
  • 10. Outcome of embryonic PCV2- infection Surgical ET HB 6 dpins PCV2/mock Inspection of ovaries (follicles/CL) Euthanasia D14 post ET Collection & analysis of embryos
  • 11. Outcome of embryonic PCV2- Sow infection Embryos Embryos Ovaries n° at transfer at euthanasia n° n° normal degenerated A statu 19 19 0 CL B s 17 15 2 CL 26 mock C 26 mock 13 7 6 CL D 3 0 3 CL E 20 0 0 0 follicles F PCV 0 0 0 follicles G 2 0 0 0 follicles 23 mock normal PCV embryo 2 20 PCV2 PCV degenerated 2 embryo
  • 12. Outcome of embryonic PCV2- Sow infection Embryos Embryos Ovaries n° at transfer at euthanasia n° n° normal degenerated A statu 19 19 0 0 CL B s 17 15 0 2 0 CL 26 mock C 26 mock 13 74 66 CL D 3 0 33 CL E 20 0 0 0 follicles F PCV 0 0 0 follicles G 2 0 0 0 follicles IHC-PCV2 23 PCV 2 20 PCV 2
  • 13. Outcome of embryonic PCV2- Sow infection Embryos Embryos Ovaries n° at transfer at euthanasia n° n° normal degenerated A statu 19 19 0 0 CL B s 17 15 0 2 0 CL 26 mock C 26 mock 13 74 66 CL D 3 0 33 CL E 20 0 0 0 follicles F PCV 0 0 0 follicles G 2 0 0 0 follicles IHC-PCV2 23 PCV2 infection of embryos leads to PCV • embryonic death 2 20 • return to oestrus of sow (regular/irregular) PCV • both PCV2a and PCV2b 2
  • 14. 2. Viremia + transplacental spread DNA-viruses (PPV, PCV2, ADV) RNA-viruses (PRRSV, CSFV, PEV 1, 3, 6 & 8, EMCV) • Cell-free: PPV, PEV, PRRSV, EMCV • Cell-associated: ADV, PCV2, CSFV
  • 15. Transplacental spread - cell free virus PRRSV (> 70dpi) * * PPV, PEV, EMCV * * * *
  • 17. Transplacental spread - PRRSV - 1. cell free virus + free mø
  • 18. Transplacental spread - PRRSV - 2. cell free virus + migrating mø
  • 19. Transplacental spread - PRRSV - 3. infection of migrating mø
  • 20. Transplacental spread - PRRSV - 4. entry of fetal placenta by migrating mø
  • 21. Transplacental spread - PRRSV - 5. explosive replication in fetal placental mø
  • 22. Transplacental spread - PRRSV - 6. apoptosis in infected mø and bystander cells
  • 23. Transplacental spread - PRRSV - 7. apoptosis in infected mø and bystander cells/necrosis?
  • 24. Transplacental spread - PRRSV - 8. dysfunction placenta
  • 25. Transplacental spread - PRRSV - 8. dysfunction placenta
  • 26. Transplacental spread - cell-associated virus PCV2, ADV, CSFV * * * * * * * * * * * * ** * * * * * * **
  • 27. Cell-associated transplacental spread of ADV Maternal placenta Maternal Fetal placenta placenta
  • 29. Clinical outcome - fetus Infection time (days of gestation) 0-30 30-60 60-90 90-113 ADV † † † † PPV † † †/IR IR PCV2 † † †/IR IR PRRSV - (†) † †/IR PEV † † †/IR IR CSFV † †/IT †/IR †/IR terato IR immune response IT immune tolerance
  • 30. Clinical outcome - sow Infection time (days of gestation) 0-30 30-60 60-90 90-113 ADV repeat br. abortion abortion abortion/msw PPV repeat br. msw msw normal PCV2 repeat br. msw msw normal PRRSV - - late abortion/msw late abortion/msw PEV repeat br. msw msw normal CSFV repeat br. abortion/msw abortion/msw abortion/msw msw: mummies, stillborn and weakborn piglets at birth
  • 31. ADV
  • 32. PPV Inoculated po at 47 days of gestation Natural case Euthanized at 81 days of gestation At birth
  • 33. Inoculated at 43 days of gestation PPV Euthanized at 98 days of gestation
  • 34. PCV2 Inoculated Aspect Virus Abs Intra-uterine Interruption (days of gestation) at birth spread of gestation 57 mummified + - + - 75 stillborn + + - - autolytic 92 normal + + - - mummified autolytic normal
  • 35. PCV2 inoculated at 57 days of gestation collected at 21 days PI Ascites, congestion of internal organs Myocarditis At birth mummified
  • 36. PRRSV
  • 37. PEV Inoculated in fetus 8 at 59 days of gestation Hysterectomy at 113 days of gestation 7 living fetuses
  • 38. CSFV Inoculation of CSFV (low virulence) po at 43 days of gestation Collection at parturition
  • 39. Reproductive failure - Diagnosis? Main complaint: abortion ≠ stages of gestation Fetuses Fetuses fresh, rigor mortis (firm) not fresh, partially mummified Sera sow Lungs/spleen fetuses (esp. with necrotic foci in liver) No serum sows!!! Seroconversion SIV or other pathogen Immunofluorescence causing general disease Virus isolation/PCR fever ADV, CSFV
  • 40. Reproductive failure - Diagnosis? Main complaint: SMEDI Fetuses/piglets at birth Mummies (≠ stages), stillborn and normal piglets 1) Heart/spleen/lungs fetuses (<70 dpins; <17cm) 2) Body fluid/serum fetuses (>70dpins; >17cm) No serum sows!!! 1) Virus isolation/PCR 2) Antibody detection (BE CAREFULL WITH PCV2!!!) PPV, PCV2, PEV, EMCV
  • 41. Reproductive failure - Diagnosis? Main complaint: late abortion/early farrowing Fetuses at late abortion/early farrowing Early stages of mummification (brown), stillborn and normal piglets Placenta/lungs/spleen fetuses Serum stillborn/piglets before colostrum uptake No serum sows!!! Virus isolation(±)/PCR PRRSV
  • 42. Virus-embryo/fetus work Laboratory of Virology & Laboratory of Reproductive Technology Faculty of Veterinary Medicine Ghent University, Belgium H. Nauwynck A. Van Soom G. Labarque R. Sanchez G. Vanroose S. Tanghe B. Mateusen P. Meerts D. Lefebvre D. Saha U. Karniychuk I. Trus J. Beek